Turmeric and black pepper extract shows promise in slowing early cancers

NCT ID NCT04731844

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a daily supplement of curcumin (from turmeric) and piperine (from black pepper) in 30 people with early-stage prostate cancer or pre-cancerous blood conditions (MGUS or low-risk smoldering multiple myeloma). The goal was to see if the supplement could lower cancer markers or prevent the disease from getting worse over 12 months. While the treatment is not a cure, it may offer a natural way to help manage these conditions and delay the need for stronger treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Rochester

    Rochester, New York, 14623, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.